NCT06360588 2026-03-17Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)National Cancer Institute (NCI)Phase 2 Active not recruiting22 enrolled 9 charts